Home LiteratureArticle Details
PMID: 27720904 Published · ppublish English

Endogenous DNA Damage Leads to p53-Independent Deficits in Replicative Fitness in Fetal Murine Fancd2 Hematopoietic Stem and Progenitor Cells.

Stem cell reports ·Vol. 7 ·No. 5 ·0000-00-00

Yoon Young Me, Storm Kelsie J, Kamimae-Lanning Ashley N, Goloviznina Natalya A, Kurre Peter

Abstract

Our mechanistic understanding of Fanconi anemia (FA) pathway function in hematopoietic stem and progenitor cells (HSPCs) owes much to their role in experimentally induced DNA crosslink lesion repair. In bone marrow HSPCs, unresolved stress confers p53-dependent apoptosis and progressive cell attrition. The role of FA proteins during hematopoietic development, in the face of physiological replicative demand, remains elusive. Here, we reveal a fetal HSPC pool in Fancd2 mice with compromised clonogenicity and repopulation. Without experimental manipulation, fetal Fancd2 HSPCs spontaneously accumulate DNA strand breaks and RAD51 foci, associated with a broad transcriptional DNA-damage response, and constitutive activation of ATM as well as p38 stress kinase. Remarkably, the unresolved stress during rapid HSPC pool expansion does not trigger p53 activation and apoptosis; rather, it constrains proliferation. Collectively our studies point to a role for the FA pathway during hematopoietic development and provide a new model for studying the physiological function of FA proteins.

Keywords
Fanconi anemia bone marrow failure development hematopoiesis stem cells
Article Info
Journal
Stem cell reports
Abbr.
Stem Cell Reports
Published
0000-00-00
Indexed
2016-10-10
Updated
2016-11-23
Language
English
Country/Region
United States
NLM ID
101611300
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com